German Healthcare Services Stock News

XTRA:HTG
XTRA:HTGHospitality

European Penny Stocks To Watch In February 2026

As European markets navigate volatility, with the STOXX Europe 600 Index reaching new highs yet remaining relatively unchanged, investors are keenly observing potential opportunities amid AI disruption concerns. For those interested in smaller or newer companies, penny stocks—despite their outdated moniker—continue to present intriguing prospects for growth at lower price points. By focusing on stocks with strong financials and solid fundamentals, investors can uncover hidden gems that may...
XTRA:NDA
XTRA:NDAMetals and Mining

Aurubis (XTRA:NDA) Valuation Check After Upgraded Earnings Guidance And Strong First Quarter Results

Why Aurubis stock is back on investors’ radar Aurubis (XTRA:NDA) has attracted fresh attention after reporting first quarter 2026 results along with a higher earnings outlook for 2025-26, citing higher metal prices, firm copper demand, and stronger supply contracts. See our latest analysis for Aurubis. The guidance upgrade and solid first quarter results have coincided with a sharp shift in sentiment, with Aurubis delivering a 60.43% 90 day share price return and a 103.57% 1 year total...
XTRA:KWS
XTRA:KWSFood

Is KWS (XTRA:KWS) Trading Profitability For Scale After Its North American Corn Exit?

In February 2026, KWS SAAT SE & Co. KGaA reported second-quarter 2025/26 sales of €183.1 million, narrowing its quarterly net loss to €54 million, while first-half sales eased slightly to €411.3 million and the six-month net loss widened to €63.8 million. The results were shaped by improved EBITDA helped by the sale of the North American corn business and an updated full-year outlook that keeps net sales roughly in line with the prior year while emphasizing profitability and long-term...
DB:AWK
DB:AWKPharmaceuticals

3 European Stocks Estimated To Be Trading Up To 48.2% Below Intrinsic Value

As European markets navigate a landscape marked by volatility and concerns over AI disruption, the pan-European STOXX Europe 600 Index recently reached a new high before settling with modest gains. Amidst these fluctuations, identifying stocks trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.
XTRA:AT1
XTRA:AT1Real Estate

Aroundtown (XTRA:AT1) Valuation Check After Hybrid Note Repurchases And New Subordinated Issuance

Aroundtown (XTRA:AT1) has just reshaped part of its funding mix by completing offers to repurchase subordinated notes while issuing new hybrid instruments, a move focused on refinancing existing liabilities and keeping its hybrid capital portfolio broadly intact. See our latest analysis for Aroundtown. Aroundtown’s recent hybrid refinancing comes after a mixed share price pattern, with the latest €2.79 level sitting above year to date share price returns of 6.65% but alongside a 5 year total...
XTRA:MBG
XTRA:MBGAuto

How Investors May Respond To Mercedes-Benz Group (XTRA:MBG) Profit Slump, Lower Dividend And Big Tech Push

Earlier this week, Mercedes-Benz Group AG reported its weakest earnings since the pandemic, with annual operating profit almost halving after around US$1.20 billion in tariff costs, a sharp sales drop in China, and restructuring charges, while also guiding for 2026 revenue to remain around prior-year levels but group EBIT to be significantly higher and proposing a reduced €3.50 per-share dividend for 2025 (2024: €4.30). At the same time, the company is pushing its largest-ever product and...
XTRA:CON
XTRA:CONAuto Components

Continental (XTRA:CON) Valuation Check As Restructuring Into Pure Play Tire Business Gains Market Support

Restructuring pivot puts Continental (XTRA:CON) in focus Continental’s decision to spin off its Automotive division into Aumovio SE and pursue a ContiTech divestment, thereby turning itself into a focused tire business, has quickly drawn a constructive market response. See our latest analysis for Continental. That pivot has arrived alongside building momentum in the shares, with a 30-day share price return of 11.71% and a 90-day share price return of 16.87%, while the 1-year total shareholder...
XTRA:AFX
XTRA:AFXMedical Equipment

A Look At Carl Zeiss Meditec (XTRA:AFX) Valuation After Revenue Guidance Cut And Quarterly Net Loss

Carl Zeiss Meditec (XTRA:AFX) cut its revenue outlook after a weak start to the year, citing softer sales expectations in the US and China as well as pressure from China’s new volume based procurement process. See our latest analysis for Carl Zeiss Meditec. The revenue guidance cut and first quarter net loss arrived after a sharp reset in sentiment, with a 30 day share price return of 32% decline and a 1 year total shareholder return of 50.65% decline, signalling fading momentum despite...
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank Settlement Begins Clearing Monte Dei Paschi Overhang For Investors

Deutsche Bank has reached a confidential settlement with former manager Stefano Foresti in a lawsuit tied to the Monte dei Paschi accounting scandal. The agreement concludes the first of several related cases brought by former employees over their alleged involvement in the affair. The outcome may influence how remaining internal disputes linked to the scandal are handled. For you as an investor looking at XTRA:DBK, this legal development comes with the share price at €29.6. The stock has...
XTRA:MRK
XTRA:MRKPharmaceuticals

Evaluating Merck KGaA (XTRA:MRK) After Sphingolipids Growth Outlook Fuels Fresh Investor Interest

Future Market Insights projects the global sphingolipids market to reach USD 1,145.6 million by 2035, and Merck KGaA (XTRA:MRK) is identified as a key supplier of high purity sphingolipid products and delivery systems. See our latest analysis for Merck KGaA. Merck KGaA’s role in the sphingolipids market sits against a backdrop of a €127.8 share price, a 10.41% 90 day share price return, and a 5.36% year to date share price return. At the same time, the 1 year total shareholder return of a...
XTRA:NDX1
XTRA:NDX1Electrical

What Nordex (XTRA:NDX1)'s New 220 MW European Orders Mean For Shareholders

In early February 2026, Nordex SE reported new European onshore wind orders totaling 220 MW across the UK, Turkiye, Lithuania and Sweden, all bundled with multi-year service and maintenance agreements that aim to secure long-term turbine performance in both standard and cold-climate sites. These contracts highlight Nordex’s growing strength in cold-climate and community wind projects, where its anti-icing technology and long-duration service deals are becoming central to how it competes for...
XTRA:HFG
XTRA:HFGConsumer Retailing

HelloFresh (XTRA:HFG) Valuation Check After Revenue Drop And Missed Q4 2025 Guidance

HelloFresh (XTRA:HFG) is back in focus after its share price dropped sharply, following a reported 9% year on year net revenue decline and missed Q4 2025 guidance that rattled investor confidence. See our latest analysis for HelloFresh. The recent Q4 2025 miss and profit warnings have been reflected in the numbers, with a 7 day share price return of 13.86% and a year to date share price return of 11.88%. Over a longer horizon, the 1 year total shareholder return of 58.47% and 5 year total...
XTRA:PUM
XTRA:PUMLuxury

Is Puma (XTRA:PUM) Pricing In Its Long-Term Recovery After Multi-Year Share Price Slump?

If you are wondering whether PUMA's current share price really reflects the business, you are not alone. This article is built to help you frame that question clearly. PUMA recently closed at €23.45, with returns of 3.3% over 7 days, 5.0% over 30 days and 4.7% year to date, while the 1 year, 3 year and 5 year returns stand at a 19.4% decline, 59.3% decline and 71.6% decline. Recent coverage around PUMA has focused on how the brand is positioned against global sportswear peers and how...
XTRA:NCH2
XTRA:NCH2Construction

A Look At Thyssenkrupp Nucera (XTRA:NCH2) Valuation After Q1 Loss And Middle East Electrolyzer Win

Earnings and contract wins set the tone for investors thyssenkrupp nucera KGaA (XTRA:NCH2) has drawn attention after first quarter earnings showed lower sales and a small net loss, while management reiterated full year guidance and announced a large electrolyzer contract in the Middle East. See our latest analysis for thyssenkrupp nucera KGaA. At a share price of €9.37, the stock has a 1-day share price return of 2.69% and a 90-day share price return of 12.22%. The 1-year total shareholder...